Litcius/Paper detail

177Lu-FAP-2286 Therapy in a Case of Recurrent Bladder Cancer With Multiple Metastatic Lesions

Linwei Li, Jian Yang, Dengsai Peng, Yu Zhang, Yue Chen

2023Clinical Nuclear Medicine23 citationsDOI

Abstract

ABSTRACT: We reported a 73-year-old man who was diagnosed with the recurrence of bladder tumor received 177 Lu-FAP-2286 treatment. Encouragingly, radiological remission and alleviation of his symptom were noted. In addition, the patient did not have any adverse effects.

Topics & Concepts

MedicineRadiological weaponBladder cancerAdverse effectUrothelial cancerOncologyInternal medicineUrologyCancerRadiologySurgeryPeptidase Inhibition and AnalysisPneumocystis jirovecii pneumonia detection and treatmentNeuroendocrine Tumor Research Advances
177Lu-FAP-2286 Therapy in a Case of Recurrent Bladder Cancer With Multiple Metastatic Lesions | Litcius